PharVision Advisers’s HP HPQ Stock Holding History

PharVision Advisers’s Portfolio HPQ Stock Details HPQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,118	Closed	-$233K	–	93
2026 Q1	$233K	Sell	12,118 -6,906	-36%	-$134K	2.36%	1
2025 Q4	$424K	Buy	+19,024	New	+$485K	0.21%	97

Other funds holding HPQ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

PharVision Advisers's HPQ Position: Q2 2026 in Review

PharVision Advisers sold out of HP (HPQ) in Q2 2026, closing a stake of 12,118 shares — an estimated $233K sold.

PharVision Advisers first reported a position in HPQ in Q4 2025 and held it in 2 quarters. The position peaked at $424K in Q4 2025. 1,088 funds tracked by Wall St. Rank hold HPQ as of Q2 2026.

PharVision Advisers reported no remaining HP position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 12,118 HP shares in Q2 2026, an estimated $233K.
PharVision Advisers first reported a position in HP in Q4 2025 and held it in 2 quarters.
PharVision Advisers's HP position peaked at $424K in Q4 2025.
1,088 funds tracked by Wall St. Rank held HP as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.